公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | 140PD: LUX-Lung 7: A Phase IIb, global, randomised, open-label trial of afatinib vs gefitinib as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations | Park K; Tan E.-H; Zhang L; Hirsh V; O'Byrne K; Boyer M; CHIH-HSIN YANG ; Mok T; Kim M; Paz-Ares L. | Journal of Thoracic Oncology | 2 | 2 | |
2018 | Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials | Wu Y.-L; Sequist L.V; Tan E.-H; Geater S.L; Orlov S; Zhang L; Lee K.H; Tsai C.-M; Kato T; Barrios C.H; Schuler M; Hirsh V; Yamamoto N; O'Byrne K; Boyer M; Mok T; Peil B; Märten A; Chih-Hsin CHIH-HSIN YANG ; Paz-Ares L; Park K. | Clinical Lung Cancer | 56 | 41 | |
2016 | Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): A phase 2B, open-label, randomised controlled trial | Park K; Tan E.-H; O'Byrne K; Zhang L; Boyer M; Mok T; Hirsh V; CHIH-HSIN YANG ; Lee K.H; Lu S; Shi Y; Kim S.-W; Laskin J; Kim D.-W; Arvis C.D; Kölbeck K; Laurie S.A; Tsai C.-M; Shahidi M; Kim M; Massey D; Zazulina V; Paz-Ares L. | The Lancet Oncology | 936 | 827 | |
2017 | Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Overall survival data from the phase IIb LUX-Lung 7 trial | Paz-Ares L; Tan E.-H; O'Byrne K; Zhang L; Hirsh V; Boyer M; CHIH-HSIN YANG ; Mok T; Lee K.H; Lu S; Shi Y; Lee D.H; Laskin J; Kim D.-W; Laurie S.A; Kölbeck K; Fan J; Dodd N; Märten A; Park K. | Annals of Oncology | 424 | 369 | |
2018 | Analysis of GWAS-linked variants in multiple system atrophy | Gu X; Chen Y; Zhou Q; Lu Y.-C; Cao B; Zhang L; MING-CHE KUO ; Wu Y.-R; RUEY-MEEI WU ; Tan E.-K; Shang H.-F; Asian Multiple System Atrophy Consortium (AMSAC) | Neurobiology of Aging | 11 | 7 | |
2021 | Are Multiseasonal Forecasts of Atmospheric Rivers Possible? | Tseng K.-C; Johnson N.C; Kapnick S.B; Delworth T.L; Lu F; Cooke W; Wittenberg A.T; Rosati A.J; Zhang L; McHugh C; Yang X; Harrison M; Zeng F; Zhang G; Murakami H; Bushuk M; Jia L.; KAI-CHIH TSENG | Geophysical Research Letters | 7 | 7 | |
2016 | AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases | Yang Z; Guo Q; Wang Y; Chen K; Zhang L; Cheng Z; Xu Y; Yin X; Bai Y; Rabbie S; Kim D.-W; Ahn M.-J; CHIH-HSIN YANG ; Zhang X. | Science Translational Medicine | 82 | 28 | |
2020 | Custom-tailoring metal-organic framework in thin-film nanocomposite nanofiltration membrane with enhanced internal polarity and amplified surface crosslinking for elevated separation property | Lin Y; Wu H.-C; Shen Q; Zhang L; Guan K; Shintani T; Tung K.-L; Yoshioka T; Matsuyama H.; KUO-LUN TUNG | Desalination | | | |
2022 | Domestic wastewater causes nitrate pollution in an agricultural watershed, China | Cao M; Hu A; Gad M; Adyari B; Qin D; Zhang L; Sun Q; Yu C.-P.; CHANG-PING YU | Science of the Total Environment | 32 | 25 | |
2019 | First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression | Schuler M; Tan E.-H; O'Byrne K; Zhang L; Boyer M; Mok T; Hirsh V; CHIH-HSIN YANG ; Lee K.H; Lu S; Shi Y; Kim S.-W; Laskin J; Kim D.-W; Arvis C.D; Kölbeck K; Massey D; Märten A; Paz-Ares L; Park K. | Journal of Cancer Research and Clinical Oncology | 29 | 27 | |
2018 | Free-breathing abdominal MRI improved by Repeated k-t-subsampling and artifact-minimization (ReKAM) | Chu ML; Chang HC; Chung HW; Bashir MR; Cai J; Zhang L; Sun D; Chen NK; HSIAO-WEN CHUNG | Medical Physics | 5 | 4 | |
2021 | Horizontal and vertical gene transfer drive sediment antibiotic resistome in an urban lagoon system | Wang H; Hou L; Liu Y; Liu K; Zhang L; Huang F; Wang L; Rashid A; Hu A; Yu C.; CHANG-PING YU | Journal of Environmental Sciences (China) | 40 | | |
2022 | Mechanisms of Regional Arctic Sea Ice Predictability in Two Dynamical Seasonal Forecast Systems | Bushuk M; Zhang Y; Winton M; Hurlin B; Delworth T; Lu F; Jia L; Zhang L; Cooke W; Harrison M; JOHNSON N.C; Kapnick S; Mchugh C; Murakami H; Rosati A; Tseng K.-C; WITTENBERG A.T; Yang X; Zeng F.; KAI-CHIH TSENG | Journal of Climate | 8 | 7 | |
2015 | Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens | Paz-Ares L; Hirsh V; Zhang L; De Marinis F; CHIH-HSIN YANG ; Wakelee H.A; Seto T; Wu Y.-L; Novello S; Juhász E; Arén O; Sun Y; Schmelter T; Ong T.J; Penã C; Smit E.F; Mok T.S. | Journal of Thoracic Oncology | 98 | 88 | |
2021 | OpenMPL: An Open-Source Layout Decomposer | Li W; Ma Y; Sun Q; Zhang L; Lin Y; Jiang I.H.-R; Yu B; HUI-RU JIANG | IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems | 5 | 4 | |
2018 | Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer | Wu Y.-L; Zhang L; Kim D.-W; Liu X; Lee D.H; CHIH-HSIN YANG ; Ahn M.-J; Vansteenkiste J.F; Su W.-C; Felip E; Chia V; Glaser S; Pultar P; Zhao S; Peng B; Akimov M; Tan D.S.W. | Journal of Clinical Oncology | 245 | 211 | |
2017 | Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer) | Nokihara H; Lu S; Mok T.S.K; Nakagawa K; Yamamoto N; Shi Y.K; Zhang L; Soo R.A; CHIH-HSIN YANG ; Sugawara S; Nishio M; Takahashi T; Goto K; Chang J; Maemondo M; Ichinose Y; Cheng Y; Lim W.T; Morita S; Tamura T. | Annals of Oncology | 74 | 68 | |
2022 | Roles of Meridional Overturning in Subpolar Southern Ocean SST Trends: Insights from Ensemble Simulations | Zhang L; Delworth T.L; Kapnick S; He J; Cooke W; Wittenberg A.T; Johnson N.C; Rosati A; Yang X; Lu F; Bushuk M; McHugh C; Murakami H; Zeng F; Jia L; Tseng K.-C; Morioka Y.; KAI-CHIH TSENG | Journal of Climate | 2 | 3 | |
2021 | Seasonal prediction and predictability of regional antarctic Sea ice | Bushuk M; Winton M; Haumann F.A; Delworth T; Lu F; Zhang Y; Jia L; Zhang L; Cooke W; Harrison M; Hurlin B; Johnson N.C; Kapnick S.B; McHugh C; Murakami H; Rosati A; Tseng K.-C; Wittenberg A.T; Yang X; Zeng F.; KAI-CHIH TSENG | Journal of Climate | 21 | 17 | |
2019 | Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer | Park K; Bennouna J; Boyer M; Hida T; Hirsh V; Kato T; Lu S; Mok T; Nakagawa K; O'Byrne K; Paz-Ares L; Schuler M; Sibilot D.M; Tan E.-H; Tanaka H; Wu Y.-L; CHIH-HSIN YANG ; Zhang L; Zhou C; Märten A; Tang W; Yamamoto N. | Lung Cancer | 26 | 26 | |